Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy.

MLA

Reschke, Robin, and Daniel J. Olson. “Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A ‘Hot’ Tumor Microenvironment That Is Responsive to Immunotherapy.” Cancers, vol. 14, no. 10, May 2022, p. 2458–N.PAG. EBSCOhost, https://doi.org/10.3390/cancers14102458.

APA

Reschke, R., & Olson, D. J. (2022). Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A “Hot” Tumor Microenvironment That Is Responsive to Immunotherapy. Cancers, 14(10), 2458–N.PAG. https://doi.org/10.3390/cancers14102458

Chicago

Reschke, Robin, and Daniel J. Olson. 2022. “Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A ‘Hot’ Tumor Microenvironment That Is Responsive to Immunotherapy.” Cancers 14 (10): 2458–N.PAG. doi:10.3390/cancers14102458.